These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7507125)

  • 21. Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection--correlation with clinical progression, viral load, and loss of humoral immunity.
    Samuelsson A; Broström C; van Dijk N; Sönnerborg A; Chiodi F
    Virology; 1997 Nov; 238(2):180-8. PubMed ID: 9400591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variable gene usage, physiology and development of Ly-1+ (CD5+) B cells.
    Hardy RR
    Curr Opin Immunol; 1992 Apr; 4(2):181-5. PubMed ID: 1376603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B cell activation and HIV infection: protective or potentially detrimental response?
    Amadori A; Chieco-Bianchi L
    Int Rev Immunol; 1992; 9(1):15-24. PubMed ID: 1484267
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence for B cell-mediated activation of V delta 1+ T lymphocytes during progression of HIV infection.
    Hyjek EM; Bartkowiak J; Drozdz R; Wasik TJ; Jasinski M; Kaneko Y; Lischner HW; Kozbor D
    J Immunol; 1997 Jan; 158(1):464-74. PubMed ID: 8977224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levels of CD5+ B lymphocytes do not differ between patients with myasthenia gravis and healthy individuals.
    Yi Q; Ahlberg R; Pirskanen R; Lefvert AK
    Neurology; 1992 May; 42(5):1081-4. PubMed ID: 1374547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of the expression of CD5 antigen on the surface of human peripheral B lymphocytes.
    Kawamura M; Wheeler CJ; Notkins AL; Bich-Thuy LT
    Cell Immunol; 1994 Nov; 159(1):61-76. PubMed ID: 7525082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Memory B-cell depletion is a feature of HIV-2 infection even in the absence of detectable viremia.
    Tendeiro R; Fernandes S; Foxall RB; Marcelino JM; Taveira N; Soares RS; Baptista AP; Cavaleiro R; Gomes P; Victorino RM; Sousa AE
    AIDS; 2012 Aug; 26(13):1607-17. PubMed ID: 22695303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells.
    Brezinschek HP; Foster SJ; Brezinschek RI; Dörner T; Domiati-Saad R; Lipsky PE
    J Clin Invest; 1997 May; 99(10):2488-501. PubMed ID: 9153293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The CD5+ B cell: a B cell lineage with a central role in autoimmune disease?
    Calvert JE; Duggan-Keen MF; Smith SW; Givan AL; Bird P
    Autoimmunity; 1988; 1(3):223-40. PubMed ID: 2485124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased CD5+CD19+ B lymphocytes at the onset of type 1 diabetes in children.
    De Filippo G; Pozzi N; Cosentini E; Cavalcanti M; Carel JC; Tamasi S; Franzese A; Pignata C
    Acta Diabetol; 1997 Dec; 34(4):271-4. PubMed ID: 9451471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD5+ B cells and naturally occurring autoantibodies in cancer patients.
    Stein R; Witz IP; Ovadia J; Goldenberg DM; Yron I
    Clin Exp Immunol; 1991 Sep; 85(3):418-23. PubMed ID: 1716541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation and high frequency expression of autoantibody-associated cross-reactive idiotypes linked to the VHI subgroup in CD5-expressing B lymphocytes from patients with chronic lymphocytic leukaemia (B-CLL).
    Shokri F; Mageed RA; Richardson P; Jefferis R
    Scand J Immunol; 1993 Jun; 37(6):673-9. PubMed ID: 7686301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD5+ B lymphocytes and T-cell subsets in a case of juvenile rheumatoid arthritis.
    Ambrogi F; Ricciardi L; Nutini P; Vanacore R
    Ann N Y Acad Sci; 1992 May; 651():564-9. PubMed ID: 1376077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of age on the expressed B cell repertoire: role of B cell subsets.
    Hu A; Ehleiter D; Ben-Yehuda A; Schwab R; Russo C; Szabo P; Weksler ME
    Int Immunol; 1993 Sep; 5(9):1035-9. PubMed ID: 7694639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proliferation and differentiation of human CD5+ and CD5- B cell subsets activated through their antigen receptors or CD40 antigens.
    Defrance T; Vanbervliet B; Durand I; Briolay J; Banchereau J
    Eur J Immunol; 1992 Nov; 22(11):2831-9. PubMed ID: 1385152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic characterization of human B-lymphocyte subpopulations, particularly human CD5+ B-lymphocyte subpopulation within the mantle zones of secondary follicles.
    Abe M; Tominaga K; Wakasa H
    Leukemia; 1994 Jun; 8(6):1039-44. PubMed ID: 7516026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoregulatory capability of murine CLL-like CD5+ B cells.
    Phillips J; Raveché E
    Ann N Y Acad Sci; 1992 May; 651():488-90. PubMed ID: 1376068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of IgD and CD20 by ligation of CD5 on tonsillar B cells.
    Morikawa K; Torii I; Morikawa S
    Scand J Immunol; 2002 Jan; 55(1):44-52. PubMed ID: 11841691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD5+ B cell-dependent regulation of the murine T-cell independent immune response against the human blood group A antigen.
    Néron S; Lemieux R
    Immunol Invest; 1997; 26(5-7):631-47. PubMed ID: 9399105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of CD5 and CD72 on T and B cell subsets in rheumatoid arthritis and Sjögren's syndrome.
    Jamin C; Lamour A; Pennec YL; Hirn M; Le Goff P; Youinou P
    Clin Exp Immunol; 1993 May; 92(2):245-50. PubMed ID: 7683586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.